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Background: Cell and tissue homeostasis results from the dynamic balance of cell – cell and cell – extracellular component crosstalk 
that regulates proliferation, differentiation, and apoptosis of cells as well as secretion and activation of soluble factors and/or deposi-
tion of extracellular matrix (ECM) components. Aim: The aim of the work was to study the crosstalk between tumor cells and stromal 
cell components using noncontact co-cultivation in vitro system. Materials and Methods: Human and rat breast cancer (BC) cell lines, 
normal human fibroblasts (NHF) and endothelial cells, and aspirates of bone marrow (BM) of BC patients with different clinical course 
of the disease (groups “Remission” (BM-R) and “Progression” (BM-P)) were used in noncontact co-cultivation system in vitro. 
The cell growth, expression of epithelial-mesenchymal transition (EMT) and tumor stem cell markers (E-cadherin, vimentin, CD44), 
Ki-67, p21 and Slug were investigated using immunocytochemical analysis. Results: Analysis of expression of E- and N-cadherin, 
vimentin and Slug in BC cells has shown that T-47D and MRS-T5 cells possess mesenchymal phenotype, while MCF-7 and MRS 
cells possess mostly epithelial phenotype with a part of cells with mesenchymal patterns. Upon noncontact co-cultivation of fibroblasts 
with Т-47D or MRS-Т5 cells, BC cells acquired higher proliferative activity compared to the control cells (р < 0.05) or MCF-7 and 
MRS cells co-cultivated with fibroblasts. Upon noncontact co-cultivation of Т-47D cells with normal fibroblasts and BM cells from 
BC patients from group “Progression” there were observed increased quantity of CD44+ Т-47D cells (by 26%), decreased quantity 
of Е-cadherin+ Т-47D cells, and appearance of vimentin-positive cells. In co-cultivation variant Т-47D + NHF + BM-R (“Remis-
sion“) the quantity of CD44+ Т-47D cells significantly decreased (р < 0.005) and E-cadherin expression remained unaltered compared 
to control cells. At the same time, in NHF cell population (co-cultivation variant Т-47D + NHF + BM-P) there was detected sig-
nificant increase of quantity of р21+-cells (р < 0.005), cytoplasmic localization of p21, and nuclear localization of Slug. Expression 
of vimentin did not alter in any variant of co-cultivation. Conclusion: The new integration cell system for investigation of the mechanisms 
of interaction between tumor cells and the tumor microenvironment in vitro was developed. The significant changes in proliferative 
activity of TC dependently on its  ЕМT-status were detected after their interaction with fibroblasts and endothelial cells in noncontact 
co-cultivation system. BM cells of BC patients had different modifying influence on TC dependent on clinical BC course. The activa-
tion of ЕМT program was revealed in TC upon noncontact co-cultivation with BM cells of BC patients with progression of the disease.
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In most cases the cancer-related mortality is caused 
by haematogenous spread of cancer cells into distant 
organs and their subsequent growth to overt metastases. 
After surgical removal of the primary tumor, minimal re-
sidual disease (MRD) is defined as the presence of tumor 
cells (TC) that are not detectable by the current routine 
diagnostic procedures used for tumor staging in cancer 
patients, but become apparent after a period of time [1]. 
The crosstalk between tumor and cells of its microenviron-
ment crucially determines the fate of tumor progression. 
The stroma is a very heterogeneous milieu including vari-
ous cell types and adhesion molecules, both contributing 
to the functional activity and structural support of the tumor 
microenvironment (TME) [2]. S. Paget laid the foundations 
of the TME research area by formulating the seed and 
soil theory. The tumor is directed into one or several pos-
sible molecular evolution pathways by signals originating 
in native and/or modified microenvironmental factors. 
Many of these pathways may lead to metastasis. The TME 
has some characteristics: 1) the molecular composi-
tion of the TME is established by TC and by resident/
infil trating non-tumor cells; 2) intercellular interactions 
between TC and components of their microenvironment 
are crucial in determining cancer progression; 3) tumor — 
microenvironment interactions are bidirectional; 4) certain 
tumor — microenvironment interactions may initiate tumor 
progression ; 5) microenvironmental factors play opposing 
roles in tumor progression by either promoting or alterna-
tively antagonizing this process [3].
The TME was recognized as the product of a de-
veloping crosstalk between different cells types: endo-
thelial cells, carcinoma-associated fibroblasts (CAFs), 
adipocytes, mesenchymal cells, mesenchymal stem cells 
(MSCs; bone marrow derived — (BM-MSCs), or carcino-
ma-associated (CA-MSCs)), and cells from the immune 
and inflammatory systems (tumor-associated macro-
phages (TAM), regulatory T cells, etc.). The stromal cells 
interact not only with TC but also with each other. TC in-
duce changes in fibroblasts, which contact with them [4], 
transforming them into myofibroblasts, which activate 
program of epithelial-mesenchymal transition (EMT) 
in TC resulting in the domination of mesenchymal features 
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and development of highly metastatic phenotype [5]. All 
these processes take place with involvement of soluble 
(humoral) factors of microenvironment (cytokines, growth 
factors, etc.), which, in turn, activate other links of interac-
tion, involved in “malignant transition”, in particular, tran-
scriptional factors. In the result of this, epithelial cells lost 
the capacity to form dense intercellular contacts, their 
adhesive properties decrease while capacity for inva-
sion and migration develop. However, when such cells 
achieve their “destination point”, the inverse process 
takes place — mesenchymal-epithelial transition (MET), 
during which they again acquire epithelial phenotype with 
increased adhesion that gives opportunity to them to fas-
ten onto the substrate and to give growth to se condary 
metastatic focus [6]. Thus, a major TAM-derived inflam-
matory cytokine shown to be highly expressed in breast 
carcinomas is tumor necrosis factor alpha (TNF-α) which 
is a multifactorial cytokine. TNF-α activity varies under 
different physiological conditions and in a cell-type-
dependent manner contributes to a sense of ambiguity 
regarding its antitumor effects. Indeed, the permanent 
expression of TNF-α in breast tumors actually supports 
tumor growth and plays a role in the metastatic behavior 
of breast carcinomas [7]. Furthermore, in BM of breast 
cancer  (BC) patients with advanced cancer significantly 
higher TNF-α concentration was detected [8]. Therefore, 
the further study of intercellular interaction and cell trans-
differentiation may reveal new targets in antimetastatic 
therapy.
It is well known that certain organs and tissues are 
typical as dominant sites of metastasis for many types 
of tumor. For example, bone marrow (BM) and bones 
often become such distant sites in BC. Today is well 
known the important role of stromal cells, in particular 
fibroblasts, as elements of TME, in control of their phe-
notype and biological behavior [9]. However, the role 
of BM cells as components of TME is poorly understood. 
Therefore, th e determination of influence of BM cells, 
especially in comparative aspect with fibroblast elements, 
on the phenotypic conversion and proliferative activity 
of cells of BC at their co-cultivation, is of special interest.
In routine practice for in vitro research of compounds 
of different nature (antitumor drugs, cytotoxic factors) 
isolated cell cultures (primary cell cultures and stable 
cell lines) are used. Experimental systems in vitro with 
use of human cell lines represent important instrument 
for estimation of the level and mechanisms of toxicity 
of antitumor drugs with the aim of precise definition 
of their possible antitumor action in vivo. The main 
disadvantage of such in vitro system is an absence 
of numerous components of interaction, which exist 
in vivo. The principally new approach for determination 
of intercellular interaction in vitro has been developed 
by A.P. Li and co-authors [10] who created a system 
of integrated discrete cultures of normal cells of diffe-
rent histogenesis and BC cells for the study of simulta-
neous combined toxic action of drugs on the  TC-targets 
and on the normal cells of organism (liver, kidneys, 
lungs, vascular endothelium, etc.). The same scheme 
with some modification has been developed by us for 
 testing the toxicity of chemical compounds, in par-
ticular, heavy metal salts, in vitro, so-called multi-organ 
system of toxicity (MOST) [11]. For investigation of cel-
lular interaction in progression of disease, we have 
developed in this work new cellular system with use 
of primary and stable cell lines of different genesis: hu-
man and rat BC TC, normal human fibroblasts (NHF) and 
normal rat fibroblasts (NRF), normal porcine endothelial 
cells (PAE), cells from BM aspirates from BC patients 
with different disease stage.
The aim of the work was to study in vitro the crosstalk 
between TC and stromal cell components using noncon-
tact co-cultivation in vitro system.
MATERIALS AND METHODS
Clinical materials. In co-cultivation in vitro system, 
mononuclear cells (MC) isolated from BM of BC pa-
tients with II and III stages of the disease (n = 6), were 
used. BC patients were cured in Rivne Regional On-
cological Hospital (Rivne, Ukraine). The patients were 
informed about the survey and provided written consent 
for participation in the research. The study was carried 
out with approval of the local Ethics Committee (R.E. Ka-
vetsky Institute of Experimental Pathology, Oncology 
and Radiobiology, NAS of Ukraine).
After conducted treatment (radical surgical inter-
vention and adjuvant chemotherapy) BC patients have 
been distributed into 2 groups: “Progression” (n = 3) and 
“Remission” (n = 3), at the basis of their clinical state, 
presence of TC in BM and high level of tumor-associated 
cytokines in plasma of BM and peripheral blood [12, 13].
The BM aspirates (3–4 ml) were taken from sternum 
with an incision in the skin to avoid contamination with 
epithelial cells. BM samples were obtained from BC pa-
tients prior to therapy.
MC were isolated by Ficoll-Hypaque density gradient 
LSM 1077 (PAA, Austria) centrifugation at 1,500 rpm for 
20 min. MC  were washed three times with RPMI-1640 and 
were cryopreserved (3–5•106 cells per vial).
Cell lines. In our co-cultivation study the following 
cell lines were used: NHF, NRF of Wistar rats, normal 
porcine endothelial cells (PAE), human BC cell lines — 
T-47D and MCF-7 and their sublines modified by long-
term action of interferon (IFN) (MCF-7 + IFN and T-47D 
+ IFN), rat mammary carcinoma — MRS [14, 15], which 
are characterized by domination in population of low 
tumorigenic cells with epithelial phenotype as well 
as highly tumorigenic subline MRS-T5, which is cha-
racterized by the presence of cells of only me senchymal 
phenotype. All cell lines have been obtained from Bank 
of Cell Lines from Human and Animal Tissues of R.E. Ka-
vetsky Institute of Experimental Pathology, Oncology 
and Radiobiology of National Academy of Sciences 
of Ukraine (Kyiv, Ukraine).
The modeling system of noncontact cell co-cul-
tivation. The cells of different type which were cultured 
separately, serve as control (Fig. 1, a). For co-cultivation 
experiment, the wells were combined with each other via 
specially made channels in the wall of wells in such a way 
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that interaction of cells through their nutrient medium 
could occur (Fig. 1, b).
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Fig. 1. Scheme of noncontact co-cultivation in vitro: a — control 
wells — isolated; b — wells with noncontact co-cultivation
Cells were cultivated in plastic glassware (“ТРР”, 
Italy) in DMEM medium (“PAA”, Austria), which contained 
2 mM of L-glutamine and NaHCO3 with 10% of FBS 
(“PAA”, Austria) in humidified atmosphere at 37 °С and 5% 
CO2. Quantity of cells after their co-cultivation has been 
determined by staining with crystal violet (“Sigma”, USA) 
with further registration of optical density of well content 
using multiwell spectrometer (Labsystems Multiskan 
PLUS, Finland) [16].
Immunocytochemical analysis. The slides of cyto-
spins were fixed in methanol + acetone (1:1) solution for 
2 h at −20 °С, and then incubated with 1% BSA solution for 
20 min. For immunocytochemical analysis, the following 
monoclonal antibodies have been applied: anti-E-cad-
herin (Thermo Scientific, UK), anti-CD325 ( N-Cadherin) 
(BioLegend, USA), anti-vimentin (Diagnostic BioSys-
tems, USA), anti-CD44 (Diagnostic BioSystems, USA), 
Slug (GeneTex, USA), р21/waf1 (NeoMarkers, USA), 
Ki-67 (Thermo Scientific, UK). Primary antibodies were 
used according to the instructions of manufacturers. For 
visualization, Poly Vue system (Thermo Scientific, UK) was 
used. The slides were also stained with Mayer’s hema-
toxylin (“Sigma”, USA) and examined using microscope 
AxioVert (“Сarl Zeiss”, Germany) with ×320 magnification. 
Data were analyzed by calculation of positive (+) cells 
using classical H-score method:
S = 1В•A + 2В•B + 3В•C,
where S — H-score index, which value lies within 
the limits from 0 (no expression) to 300 (intensive ex-
pression in 100% of cells); А — percentage of poorly 
stained cells; В — percentage of moderately stained cells; 
C — percen tage of strongly stained cells.
Statistics. Statistical processing of obtained re-
sults has been carried out using mathematical program 
STATISTIСA 6.0. Significance of differences between 
mean values has been conducted with use of Stu-
dent’s t-criterion.
RESULTS AND DISCUSSION
First of all, the expression of ЕМT markers (E- and 
 N-cadherin, vimentin and Slug) was analyzed in TC which 
were cultured separately as a control and later were used 
in noncontact co-cultivation system. It was found that 
the mesenchymal antigen expression profile was the most 
typical for cells of T-47D and MRS-T5 lines. MCF-7 and 
MRS cell lines are characterized by the prevalence of cells 
with epithelial phenotype with the presence of cells with 
mesenchymal features (Table).
Then, TC and stromal elements (fibroblasts, endo-
thelial cells) were co-cultivated in vitro using the system 
described above. In the case of co-cultivation of TC and 
fibroblasts, the proliferation of fibroblasts was close 
to that of control cells but the quantity of TC varied de-
pendently on domination of epithelial or mesenchymal 
phenotype of these cells. In particular, the quantity 
of TC with domination of mesenchymal features (Т-47D, 
MRS-Т5 cells) in noncontact co-cultivation with fibroblasts 
was more prominently increased compared to control cells 
(р < 0.05), than quantity of TC with prevalence of epithelial 
phenotype (MCF-7, MRS) (Fig. 2). In the case of co-culti-
vation of fibroblasts (RNF) with rat TC with me senchymal 
or epithelial features (variant of co-cultivation MRS + 
RNF + MRS-T5) significant inhibition of MRS-T5 cells 
with me senchymal phenotype in presence of epithelial 
MRS cells was detected (see Fig. 2). So, the cells with 
more differentiated epithelial phenotype may significantly 
repress growth potential of cells with mesenchymal phe-
notype [17].
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Fig. 2. Quantity of viable NHF and human TC (a) and NRF and rat 
TC (b) upon their combined noncontact co-cultivation. OY axis rep-
resents the percent of viable cells compared to respective control 
cells cultured in separate wells (taken as 100% of viable cells)
It is well known that tumor and stromal cells in microen-
vironment can interact and crosstalk between them might 
be bidirectional. Tumor angiogenesis is a prerequisite for 
tumor progression and metastasis. It is a complex process 
Table. EMT marker expression in human BC cell lines
Antigens E-cadherin N-cadherin Slug
TC T-47D MCF-7 MRS T5 T-47D MCF-7 MRS T5 T-47D MCF-7 MRS T5E M E M E M
Scores (H-score system) 98±11 126±7 270±21 22±9 39±4 81±11 53±3 72±8 221±28 174±16 136 ±21 54±10 156±26 224±32 269±11
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that requires cooperative reciprocal interaction of tumor 
and endothelial cells and involves soluble and cellular 
components. This requires a coordinated expression 
of proangiogenic factors and suppression of antiangio-
genic factors, which leads to endothelial cell proliferation, 
migration and vessel formation. M. Buess et al. [18] sug-
gest that the interaction of endothelial cells with TC that 
express the CD44+/CD24− signature (indicating a low pro-
liferative potential) might explain association of the CD44+/
CD24− signature with highly proliferative tumors that have 
an unfavorable prognosis.
The differences in proliferative activities of human 
BC cells (control cells and IFN-modified cells) in co-
cultivation with cellular TME components (fibroblasts 
and endothelial cells) were identified. For this study, 
we used the following design of noncontact cultivation 
cell system:
• set 1: 1) MCF-7/MCF-7 (IFN modified) + NHF; 
2) MCF-7/MCF-7 (IFN modified) + PAE;
• set 2: 1) T-47D/T-47D (IFN modified) + NHF; 
2)  T-47D/T-47D (IFN modified) + PAE.
So, we obtained the following results: using 
MCF-7 cell line and MCF-7 + IFN subline, we observed 
an inhibition the BC proliferation independently on vari-
ant of stromal cells (NHF or PAE). This inhibition was 
more significant in the case with MCF-7 + IFN cells 
(20–25%) compared with control cells (Fig. 3). 
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Fig. 3. Proliferative activities of MCF-7 (a) and IFN-modified 
MCF-7 (b) cells in noncontact co-cultivation system with NHF 
and PAE cells. OY axis represents the percent of viable cells 
compared to respective control cells cultured in separate wells 
(taken as 100% of viable cells)
Interestingly, proliferative activity of NHF and PAE 
was changed, too: quantities of stromal elements were 
higher (about 10% in case co-cultivation with PAE and 
3–20% in case co-cultivation with NHF). To explain this 
fact we will investigate the phenotype of these cells. 
It is known that tumor can induce phenotypic changes 
associated with transcriptional reprogramming of en-
dothelial cells, which can be detected by expression 
profiling: production of growth factors by TC that in-
duce endothelial cells to express specific ligands and 
their cognate receptors coordinately [19].
In another set of our study, the proliferative activi-
ties of BC and stromal cells were different indicating 
a significant interplay of cells. In particular, cultivation 
of T-47D cells with NHF or PAE as well as cultivation 
of IFN-modified T-47D cells with NHF or PAE resulted 
in increased proliferation of both cell types (Fig. 4).
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Fig. 4. Proliferative activities of T-47D (a) and IFN-modified 
T-47D (b) cells in noncontact co-cultivation system with NHF 
and PAE cells. OY axis represents the percent of viable cells 
compared to respective control cells cultured in separate wells 
(taken as 100% of viable cells)
BM is considered to be depot for TC and is di-
rect participant of MRD [20–22]. So, the influence 
of BM components to TC as an additional factor was 
studied. Cells from aspirates of BM of BC patients were 
used in new integrated system in vitro. The significant 
changes of phenotypic features of both tumor and 
normal cells in noncontact co-cultivation system with 
addition of BM cells were detected (Fig. 5): variant 
of co-cultivation Т-47D + NHF + BM (“Progression”) 
and Т-47D + NHF + BM (“Remission”). To investigate 
changes at the cellular and molecular level we decided 
to analyze the expression of some protein markers 
associated with EMT.
The investigation of expression of cell cycle regulator 
p21 has shown that the quantity of p21-positive T-47D 
cells as well as intracellular localization of p21 remained 
unchanged in different variants of co-cultivation (see 
Fig. 5, a). The subcellular localization of p21 is very 
76 Experimental Oncology 36, 72–78, 2014 (June)
important because this protein performs opposite 
functions in nucleus and cytoplasm. In particular, 
if p21 localizes in nucleus, it acts as regulator of cell 
cycle through inactivation of transcriptional factors 
Е2F1, c-Myc, STAT3 [23], as well as inhibitor of replica-
tion due to oppression of subunit of DNA-polymerase 
of δ-protein PCNА. When p21 localizes in cytoplasm, 
it performs formation of stress-fibrin and focal contacts 
that assists the migration of cells. Moreover, p21 in cy-
toplasm demonstrates antiapoptotic functions through 
decrease of proapoptotic kinases activity (ASK-1, JNK, 
p38) and inhibition of proxapase-2.
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Fig. 5. Expression of р21 (a), and CD44, Ki-67, vimentin, 
Е-cadherin (b) in T-47D cells in noncontact co-cultivation sys-
tem in vitro with NHF and BM cells. *p ≤ 0.005; **p ≤ 0.05; ***p; 
evaluation by Н-Score, scores
Next, we investigated CD44 expression. CD44 is ad-
hesion molecule, which plays important role in inter-
action “tumor — microenvironment” and is involved 
in processes of migration and invasion of TC. More-
over, CD44 is used as marker of progression and 
metastasis at different types of cancer, in particular, 
BC. TCs with phenotype CD44+CD24− are considered 
as cancer stem cells (CSC). In our study, the quantity 
of CD44-positive (CD44+) Т-47D cells were increased 
by 26% at their co-cultivation with BM cells (variant 
Т-47D + NHF + BM (“Progression”)) compared with 
control of cells in isolated wells. Interestingly, the quan-
tity of CD44+-cells was significantly decreased in vari-
ant of co-cultivation Т-47D + NHF + BM (“Remission”) 
compared to isolated control (р < 0.005) and com-
pared to these in co-cultivation variant with BM cells 
of patients from “Progression” group (р < 0.005) 
 (see Fig. 5, b).
The next step was to study of E-cadherin expres-
sion in T-47D cells in different variants of co-cultivation: 
the quantity of E-cadherin+ T-47D cells in co-cultivation 
variant Т-47D + NHF + BM (“Progression”) was de-
creased by 1.8 times compared to isolated control and 
was not changed compared to these in co-cultivation 
variant Т-47D + NHF + BM (“Remission”) (see Fig. 5, b). 
E-cadherin is a marker of epithelial phenotype. Loss 
of the E-cadherin molecule is thought to enable metas-
tasis by disrupting intercellular contacts — an early step 
in metastatic dissemination and prominently associated 
with tumor invasiveness and poor prognosis [24].
Vimentin is a protein of cytoskeleton normally ex-
pressed in cells of mesenchymal origin [25]. It is used 
widely as a marker of the EMT and can induces changes 
in cell shape, motility, and adhesion during of this pro-
cess [26]. Its expression was investigated in T-47D cells 
which were included in different variants of co-cultivation. 
Thus, this protein was not detected in control T-47D cells 
(isolated) as well as in T-47D cells of variant co-cultivation 
Т-47D + NHF + BM (“Remission”), but the expression 
of vimentin was observed in T-47D cells in co-cultivation 
with NHF and BM cells (“Progression”) (see Fig. 5, b).
Such changes of phenotypic profile of T-47D cells 
are the results of their co-cultivation with components 
of microenvironment (NHF and BM cells of BC patients 
with different BC course). These indicate the sig-
nificant influence of BM cells and humoral factors, 
which they produce, on the BC cells which depended 
on the state of tumor process in BC patients (progres-
sion or remission of the disease). The phenotypic profile 
of TC in co-cultivation variant with BM cells of BC pa-
tients of “Remission” group did not differ from control 
cells. But the activation of ЕМT program were observed 
in TC in co-cultivation variant with BM cells of BC pa-
tients of “Progression” group, which was associated 
with obtaining of more aggressive features by cells and 
possible increase of their metastatic potential.
The phenotypic profile of NHF after their co-cul-
tivation with T-47D and BM cells of BC patients with 
different courses of tumor process was changed too. 
The expression of vimentin, p21 and Slug was inves-
tigated. So, changes of expression of vimentin were 
not detected in NHF in any variants of co-cultivation. 
Changes of expression of transcription factor of me-
senchymal cells Slug were detected. In co-cultivation 
NHF with TC and BM cells of BC patients Slug was relo-
calized to the nucleus of NHF (p < 0.002). Interestingly, 
the presence of p21 protein only in cytoplasm of NHF 
was observed (Fig. 6). The quantity of p21+ NHF cells 
was significantly increased upon co-cultivation with 
BM cells of BC patients (“Progression” group) com-
pared with control (р < 0.005).
These results in some way explain the well-
known data about differentiation of fibroblasts into 
myofibroblasts in co-cultivation with TC [27]. Stro-
mal elements, which include also fibroblasts, may 
be inductors of transcription factors in TC that support 
the domination of mesenchymal features in cells. 
Such  modulations of intracellular processes occur 
through the secretion by cells of series of factors 
(cytokines, factors of growth, etc.). One of such fac-
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tors may be epi thelial-stromal interaction 1 (EPST1). 
EPST1 has been identified as interferon response 
gene exactly in co-cultivation of BC cells with stromal 
fibroblasts [28, 29]. Its expression was increased 
in postsurgical tumor material of BC patients in con-
trast to control mammary gland tissues. The highest 
intensity of expression of EPST1 was determined 
exactly in regions of tumor, which closely contacted 
with stroma [29].
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Fig. 6. Expression of р21 (a), Slug and vimentin in NHF cells upon 
noncontact co-cultivation with TC and BM cells from BC patients. 
*p < 0.005; **p < 0.005; ***p < 0.02; ****p < 0.002; evaluation 
by Н-Score, scores
In conclusion, the new integration cell system for 
investigation of the mechanisms of interaction between 
TC and TME in vitro was developed. The significant 
changes in proliferative activity of TC dependently 
on its ЕМT-status were detected after their interaction 
with fibroblasts and endothelial cells in noncontact 
co-cultivation system. BM cells of BC patients had dif-
ferent modifying influence on TC dependent on clinical 
BC course. The activation of ЕМT program was revealed 
in TC upon noncontact co-cultivation with BM cells 
of BC patients with progression of the disease.
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